For the greatest impact, end caps on PrEP access now
The Lancet HIV - "NHS England announced in January that it will fund an increase in the number of participants in the Pre-exposure prophylaxis (PrEP) Impact Trial from 13 000 to 26 000. Although approved in principle, the trial oversight board said on January 23 that it needs to further engage with local authorities and trial sites before an exact timescale for the increase is fixed.
Scheduled to end in 2020, the 3-year trial has been oversubscribed by men who have sex with men (MSM), with capacity reached in many clinics and potential participants turned away." (Photo: Jasn/flickr, CC BY-NC 2.0)